This study was carried out using 300 multiparous Najdi ewes during breeding season to compare the effects of fluorogestone acetate (FGA) sponges and controlled internal drug release (CIDR) dispensers to synchronize estrus on reproductive performance and hormonal profiles. Ewes were equally and randomly allotted into group A (FGA) and group B (CIDR); intravaginal progestagen was administered for 14-day period with intramuscular administration of 600-IU eCG at withdrawal time. Estrus was detected using a vasectomized ram starting 12 hours after progestagen withdrawal and repeated every 12 hours up to 84 hours. Blood samples were collected at the time of progestagen withdrawal (0 hour), 24 hours, and 48 hours. Follicle-stimulating hormone, LH, estradiol, and progesterone serum concentrations were measured using commercial ELISA kits and microtitrimetric plates. Timed laparoscopic insemination was performed 48 hours after progestagen withdrawal. Pregnancy and the number of fetuses were diagnosed by ultrasonography on Day 23 after insemination and confirmed on Days 35 and 60. The results revealed that the retention, vaginal discharge, and drawstring breakage rates after progestagen removal were significantly (P ≤ 0.05) higher in the FGA group (94.00, 98.58, and 9.22, respectively) than those in the CIDR group. On the other hand, pregnancy, fertility, twinning rates, and fecundity were significantly (P ≤ 0.05) higher in the CIDR group (77.86, 75.57, 34.34, and 1.02, respectively) than in the FGA group. Estrus responses in FGA and CIDR groups increased gradually to attain their significantly (P ≤ 0.05) higher percentages after 48 hours of progestagen withdrawal (91.49 and 92.37, respectively); thereafter, they decreased. The overall estrus responses and prolificacy did not differ between the FGA and CIDR groups. Follicle-stimulating hormone was significantly higher in the FGA group at 24 and 48 hours after progestagen withdrawal, whereas LH was significantly higher in the CIDR group at 48 hours after progestagen withdrawal. Estradiol and progesterone were significantly higher in the CIDR group at 0, 24, and 48 hours after progestagen withdrawal. These results indicated that although FGA and CIDR devices are efficient in synchronizing estrus in ewes, CIDR provided higher pregnancy, fertility, twinning rates, and fecundity than FGA.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.theriogenology.2015.03.018DOI Listing

Publication Analysis

Top Keywords

progestagen withdrawal
28
hours progestagen
24
fga group
16
cidr group
16
≤ 005
12
005 higher
12
higher cidr
12
fga cidr
12
group hours
12
cidr
10

Similar Publications

The study evaluated strategies for induction of ovulation at the end of timed AI (TAI) protocols initiated after a novel presynchronization strategy. A total of 909 lactating dairy cows from 6 dairy herds initiated a presynchronization protocol on d -15 with an intravaginal progesterone (P4) implant and 7 d later (d -8) were treated with 1.0 mg of estradiol cypionate (EC) and 0.

View Article and Find Full Text PDF

The aims of this study were to: 1) evaluate the impact of intravaginal progesterone (P4) inserts containing different amounts of P4 on pregnancy rates of predominantly Bos taurus beef cows exposed to fixed-time artificial insemination (FTAI) using estradiol and P4-based synchronization protocols, and 2) evaluate the impact of delayed luteolysis on the fertility of cows receiving P4 insert with less P4. Cows (n = 1744) were randomly assigned to 1 of 3 treatments: 1) 2.0 mg of estradiol benzoate together with an intravaginal P4-releasing insert containing 1.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate how effective surgical removal of Essure implants is for symptom relief and patient satisfaction both shortly after and six months post-surgery.
  • Conducted at Lille Regional University Hospital, the research involved women who had their Essure implants removed between 2016 and 2020, and included different types of surgery to perform the removal.
  • Results showed that 74% of patients experienced total symptom relief at six months, high patient satisfaction rates (97.3% would opt for the procedure again), and while many symptoms improved, some negative effects lingered.
View Article and Find Full Text PDF

Neuroendocrine mechanisms of mood disorders during menopause transition: A narrative review and future perspectives.

Maturitas

October 2024

Department of Clinical and Experimental Medicine, Division of Gynecology and Obstetrics, University of Pisa, Via Roma 67, 56126 Pisa, PI, Italy. Electronic address:

Article Synopsis
  • The menopause transition significantly increases a woman's risk of mood disorders due to fluctuations in estrogen and progesterone levels.
  • Low estradiol levels after menopause impact the central nervous system, leading to an imbalance in neurotransmission that can result in symptoms like hot flashes, depression, and anxiety.
  • The review highlights the complex neuroendocrine changes occurring during this transition, focusing on the various signaling pathways and neurotransmitters involved in mood alterations.
View Article and Find Full Text PDF

Influence of Menstrual Cycle and Oral Contraceptive Phases on Bone (re)modelling Markers in Response to Interval Running.

Calcif Tissue Int

October 2024

LFE Research Group, Department of Health and Human Performance. Faculty of Physical Activity and Sport Science, Universidad Politécnica de Madrid, Calle de Martín Fierro, 7, 28040, Madrid, Spain.

Article Synopsis
  • - The study investigated how sex hormone levels fluctuate throughout the menstrual cycle and the use of oral contraceptives (OC) affect bone metabolism markers, specifically P1NP and β-CTX-1, during exercise.
  • - Eight women with regular menstrual cycles and eight OC users performed an 8x3 minute treadmill running test, with hormonal levels measured before and after exercise across different cycle phases.
  • - Results showed significant variations in hormone levels: estrogen was lowest in the early-follicular phase and highest in the late-follicular phase; progesterone peaked in the mid-luteal phase, while post-exercise P1NP levels were notably higher in regular cycle phases compared to the active pill phase.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!